Literature DB >> 15956396

Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources.

Craig T Parker1, Sharon T Horn, Michel Gilbert, William G Miller, David L Woodward, Robert E Mandrell.   

Abstract

Campylobacter jejuni strains exhibit significant variation in the genetic content of the lipooligosaccharide (LOS) biosynthesis loci with concomitant differences in LOS structure. The C. jejuni LOS loci have been grouped into six classes based on gene content and organization. Utilizing PCR amplifications of genes from these loci, we were able to classify a majority (80%) of the LOS biosynthesis loci from 123 strains of C. jejuni that included 39 of the Penner serotype reference strains. We found that a particular LOS class was not always associated with a specific Penner serotype, and 14 of 16 Guillain-Barré syndrome-associated isolates tested in this study shared the same LOS class. The remaining isolates that could not be classified were often distinguishable from each other based on the results of gene-specific PCR and the lengths of their LOS biosynthesis loci as determined by long (XL) PCR. Sequence analysis of two of these unique XL PCR products demonstrated two new LOS classes. These results support the hypothesis that the LOS locus is a hot spot for genetic exchange and rearrangements. Analysis of the LOS biosynthesis genes by PCR assays can be used for typing C. jejuni and offers the advantage of inferring potential LOS structures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956396      PMCID: PMC1151924          DOI: 10.1128/JCM.43.6.2771-2781.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni.

Authors:  D Linton; M Gilbert; P G Hitchen; A Dell; H R Morris; W W Wakarchuk; N A Gregson; B W Wren
Journal:  Mol Microbiol       Date:  2000-08       Impact factor: 3.501

2.  Detection on surfaces and in Caco-2 cells of Campylobacter jejuni cells transformed with new gfp, yfp, and cfp marker plasmids.

Authors:  W G Miller; A H Bates; S T Horn; M T Brandl; M R Wachtel; R E Mandrell
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

3.  The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences.

Authors:  J Parkhill; B W Wren; K Mungall; J M Ketley; C Churcher; D Basham; T Chillingworth; R M Davies; T Feltwell; S Holroyd; K Jagels; A V Karlyshev; S Moule; M J Pallen; C W Penn; M A Quail; M A Rajandream; K M Rutherford; A H van Vliet; S Whitehead; B G Barrell
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

4.  Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curaçao.

Authors:  R van Koningsveld; R Rico; I Gerstenbluth; P I Schmitz; C W Ang; I S Merkies; B C Jacobs; Y Halabi; H P Endtz; F G van der Meché; P A van Doorn
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

5.  Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity.

Authors:  N Dorrell; J A Mangan; K G Laing; J Hinds; D Linton; H Al-Ghusein; B G Barrell; J Parkhill; N G Stoker; A V Karlyshev; P D Butcher; B W Wren
Journal:  Genome Res       Date:  2001-10       Impact factor: 9.043

6.  Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide.

Authors:  D Linton; A V Karlyshev; P G Hitchen; H R Morris; A Dell; N A Gregson; B W Wren
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

7.  Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-mhz (1)h and (13)c NMR analysis.

Authors:  M Gilbert; J R Brisson; M F Karwaski; J Michniewicz; A M Cunningham; Y Wu; N M Young; W W Wakarchuk
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

8.  Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni.

Authors:  P Guerry; C P Ewing; T E Hickey; M M Prendergast; A P Moran
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 9.  The immunopathogenesis of Miller Fisher syndrome.

Authors:  H J Willison; G M O'Hanlon
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

10.  The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.

Authors:  Peggy C R Godschalk; Astrid P Heikema; Michel Gilbert; Tomoko Komagamine; C Wim Ang; Jobine Glerum; Denis Brochu; Jianjun Li; Nobuhiro Yuki; Bart C Jacobs; Alex van Belkum; Hubert P Endtz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

View more
  64 in total

1.  Comparative genomic analysis of Campylobacter jejuni strains reveals diversity due to genomic elements similar to those present in C. jejuni strain RM1221.

Authors:  Craig T Parker; Beatriz Quiñones; William G Miller; Sharon T Horn; Robert E Mandrell
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

2.  Mutation of waaC, encoding heptosyltransferase I in Campylobacter jejuni 81-176, affects the structure of both lipooligosaccharide and capsular carbohydrate.

Authors:  Margaret I Kanipes; Erzsebet Papp-Szabo; Patricia Guerry; Mario A Monteiro
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

3.  Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies.

Authors:  Frédéric Poly; Timothy D Read; Yu-Han Chen; Mario A Monteiro; Oralak Serichantalergs; Piyarat Pootong; Ladaporn Bodhidatta; Carl J Mason; David Rockabrand; Shahida Baqar; Chad K Porter; David Tribble; Michael Darsley; Patricia Guerry
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

4.  Comparative characterization of the virulence gene clusters (lipooligosaccharide [LOS] and capsular polysaccharide [CPS]) for Campylobacter coli, Campylobacter jejuni subsp. jejuni and related Campylobacter species.

Authors:  Vincent P Richards; Tristan Lefébure; Paulina D Pavinski Bitar; Michael J Stanhope
Journal:  Infect Genet Evol       Date:  2012-12-29       Impact factor: 3.342

5.  Is the Campylobacter jejuni secretory protein Cj0069 a suitable antigen for serodiagnostics?

Authors:  J Corso; R Lugert; U Groß; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

6.  Characteristics of lipo-oligosaccharide loci of Campylobacter jejuni isolates associated with Guillain-Barré Syndrome from Hebei, China.

Authors:  Hai Jiang; Mao-Jun Zhang; Rui-Chun Liu; Xin-Ying Tian; Yi-Xin Gu; Jian-Zhong Zhang
Journal:  Int J Mol Sci       Date:  2010-03-19       Impact factor: 5.923

7.  Genomic characterization of the Guillain-Barre syndrome-associated Campylobacter jejuni ICDCCJ07001 Isolate.

Authors:  Maojun Zhang; Lihua He; Qun Li; Honghe Sun; Yixin Gu; Yuanhai You; Fanliang Meng; Jianzhong Zhang
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

8.  Comparative population structure analysis of Campylobacter jejuni from human and poultry origin in Bangladesh.

Authors:  Z Islam; A van Belkum; J A Wagenaar; A J Cody; A G de Boer; S K Sarker; B C Jacobs; K A Talukder; H P Endtz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-26       Impact factor: 3.267

9.  Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh.

Authors:  Zhahirul Islam; Alex van Belkum; Jaap A Wagenaar; Alison J Cody; Albert G de Boer; Helen Tabor; Bart C Jacobs; Kaisar A Talukder; Hubert P Endtz
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

10.  Campylobacter jejuni HS:23 and Guillain-Barre syndrome, Bangladesh.

Authors:  Zhahirul Islam; Alex van Belkum; Alison J Cody; Helen Tabor; Bart C Jacobs; Kaisar A Talukder; Hubert P Endtz
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.